Resmed Inc
XBER:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
XBER:RME
|
US |
|
N
|
New York Times Co
F:NYT
|
US |
|
1
|
11 Bit Studios SA
DUS:11C
|
PL |
|
P
|
Pineapple Power Corporation PLC
F:8JZ
|
UK |
|
B
|
Bel Fuse Inc
NASDAQ:BELFB
|
US |
|
D
|
Denison Mines Corp
SWB:IUQ
|
CA |
|
F
|
Franklin Resources Inc
F:FRK
|
US |
|
N
|
National Australia Bank Ltd
DUS:NAL
|
AU |
|
Richter Gedeon Vegyeszeti Gyar Nyrt
F:RIG2
|
HU |
|
Z
|
Zentek Ltd
F:ZAY0
|
CA |
|
I
|
Investigator Resources Ltd
F:VOP
|
AU |
|
Zscaler Inc
XETRA:0ZC
|
US |
|
LIC Housing Finance Ltd
BSE:500253
|
IN |
|
W
|
Workday Inc
SWB:W7D
|
US |
|
WELL Health Technologies Corp
TSX:WELL
|
CA |
|
Merdeka Copper Gold Tbk PT
OTC:PMCGF
|
ID |
|
S
|
Sinergi Inti Andalan Prima Tbk PT
IDX:INET
|
ID |
|
StarHub Ltd
SGX:CC3
|
SG |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
M
|
Mondi PLC
F:KYC
|
UK |
|
E
|
Elders Ltd
OTC:EDESY
|
AU |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
US |
|
L
|
Lakes Blue Energy NL
F:LKS
|
AU |
|
Gujarat Narmada Valley Fertilizers & Chemicals Ltd
BSE:500670
|
IN |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for
RME is 272.12 EUR with a low forecast of 179.22 EUR and a high forecast of 351.94 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
272.12
EUR
According to Wall Street analysts, the average 1-year price target for
RME is 272.12 EUR with a low forecast of 179.22 EUR and a high forecast of 351.94 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.